Logo

IsoPlexis: Siddhartha Kadia

May 26, 2021

Siddhartha Kadia has joined the board of directors of single-cell proteomics firm IsoPlexis. Previously, he was president of the life sciences division at Life Technologies; president and CEO of EAG Laboratories; and corporate VP at Invitrogen. He also serves as director of NuVasive, ALS, Applied Technical Services (ATS), and BioSkryb Genomics. Kadia holds a master's degree from Rutgers University and a PhD in biomedical engineering from Johns Hopkins University.

Breaking News
The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.